| Dr Indraneil Ray, MD, MPH | |
|
34 Maple St Fl 3, Norwalk, CT 06850-3815 | |
| (203) 855-3680 | |
| Not Available |
| Full Name | Dr Indraneil Ray |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 18 Years |
| Location | 34 Maple St Fl 3, Norwalk, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760641013 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Honorhealth Deer Valley Medical Center | Phoenix, AZ | Hospital |
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Scottsdale Osborn Medical Center | Scottsdale, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Honorhealth Ambulatory | 5991603110 | 406 |
News Archive
Sarah, a military veteran living on the coast of South Carolina, knew she had a problem. The opioids prescribed for her pain were becoming a headache of their own.
Seemingly harmless fluid-filled spaces around the cerebral small vessels, commonly seen on brain MRIs in older adults, are now thought to be associated with more compromised cognitive skills, according to a Vanderbilt University Medical Center study published in Neurology.
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that higher levels of perfluorocarbons in the body are associated with increased odds of having experienced menopause in women between 42 and 64 years old. Women in this age group with high levels of PFCs also had significantly lower concentrations of estrogen when compared to women who had low levels of PFCs.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
› Verified 9 days ago
| Entity Name | Honorhealth Ambulatory |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407050917 PECOS PAC ID: 5991603110 Enrollment ID: O20071005000449 |
News Archive
Sarah, a military veteran living on the coast of South Carolina, knew she had a problem. The opioids prescribed for her pain were becoming a headache of their own.
Seemingly harmless fluid-filled spaces around the cerebral small vessels, commonly seen on brain MRIs in older adults, are now thought to be associated with more compromised cognitive skills, according to a Vanderbilt University Medical Center study published in Neurology.
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that higher levels of perfluorocarbons in the body are associated with increased odds of having experienced menopause in women between 42 and 64 years old. Women in this age group with high levels of PFCs also had significantly lower concentrations of estrogen when compared to women who had low levels of PFCs.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Indraneil Ray, MD, MPH 34 Maple St Fl 3, Norwalk, CT 06850-3815 Ph: (203) 855-3680 | Dr Indraneil Ray, MD, MPH 34 Maple St Fl 3, Norwalk, CT 06850-3815 Ph: (203) 855-3680 |
News Archive
Sarah, a military veteran living on the coast of South Carolina, knew she had a problem. The opioids prescribed for her pain were becoming a headache of their own.
Seemingly harmless fluid-filled spaces around the cerebral small vessels, commonly seen on brain MRIs in older adults, are now thought to be associated with more compromised cognitive skills, according to a Vanderbilt University Medical Center study published in Neurology.
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that higher levels of perfluorocarbons in the body are associated with increased odds of having experienced menopause in women between 42 and 64 years old. Women in this age group with high levels of PFCs also had significantly lower concentrations of estrogen when compared to women who had low levels of PFCs.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
› Verified 9 days ago
Dr. Eve Block, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-852-2665 Fax: 203-739-8878 | |
Vittoria Gassman, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 120 Connecticut Ave, Norwalk Community Health Center, Norwalk, CT 06854 Phone: 203-899-1770 | |
Dr. Yonatan J Hillman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Stevens St Ste D, Norwalk, CT 06850 Phone: 203-852-3455 | |
Maria A Martin, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 761 Main Ave, Suite 201, Norwalk, CT 06851 Phone: 203-838-4000 Fax: 203-845-9535 | |
Xiaofei Wei, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 761 Main Ave, Suite 201, Norwalk, CT 06851 Phone: 203-838-4000 Fax: 203-845-9535 | |
Daniel Ethan Boxer, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 24 Stevens St, Norwalk, CT 06850 Phone: 203-845-4811 Fax: 203-845-4897 | |
Dr. Caitlyn Kuwata, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 34 Maple St, Norwalk, CT 06850 Phone: 203-852-2025 |